Business Wire Feed

BrainScope’s EEG-Based Biomarker Predicts Dementia Risk Up to 7 Years Before Initial Diagnosis, Published in Nature Scientific Reports

February 10th, 2026|

Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope’s strategic focus on early, actionable dementia detection.ROCKVILLE, Md.--(BUSINESS WIRE)--#brain--BrainScope, a commercial-stage medical neurotechnology company applying artificial intelligence and computational neuroscience to more...

New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval

February 10th, 2026|

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) more...

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

February 9th, 2026|

DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced it will be presenting at two upcoming investor meetings. Forte’s CEO, Paul Wagner, PhD will be more...

ZCG-Backed Unimed Acquires Regenboog Shipping Pharmacy

February 9th, 2026|

Acquisition Expands Unimed’s Netherlands Footprint and Builds on Lagaay IntegrationNEW YORK--(BUSINESS WIRE)--Universal Maritime Solutions (“Unimed” or “the Company”), a leading global provider of medical and compliance solutions to the maritime industry, today announced the acquisition more...

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.